Physician Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Physician Wealth Advisors's VRTX Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, selling an estimated $4.43K and leaving 634 shares worth $315K. The position accounts for 0.04% of the portfolio, ranked #152.

Physician Wealth Advisors first reported a position in VRTX in Q1 2021 and has held it in 11 quarters since. The position peaked at $323K in Q4 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• Physician Wealth Advisors held 634 shares of Vertex Pharmaceuticals worth $315K as of Q2 2026.
• Physician Wealth Advisors sold 10 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.43K.
• Vertex Pharmaceuticals made up 0.04% of Physician Wealth Advisors's portfolio in Q2 2026, its #152 holding.
• Physician Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
• Physician Wealth Advisors's Vertex Pharmaceuticals position peaked at $323K in Q4 2025.
• 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.